Suppressive effect of agmatine on genetically programmed death of leukocytes in a diabetes model

Cytology and Genetics

Volumn 50, Issue 4, 2016, Pages 241-250

  Ferents, I V ^a,b   Brodyak, I V ^a   Lyuta, M Ya ^a   Burda, V A ^a   Sybirna, N O ^a  

^a IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

^b Borshchahivskiy Chemicopharmaceutical Plant   (Ukraine)

Author keywords

agmatine; apoptosis; diabetes model; leukocytes

Indexed keywords

EID: 84980319987     PISSN: 00954527     EISSN: 19349440     Source Type: Journal    
DOI: 10.3103/S0095452716040034     Document Type: Article

References (44)

1. Kyyak, Y.G. and Buchko, O., The impact of diabetes type 2 in apoptosis of immune cells in the blood of patients with unstable angina, Ukraine Drugs, 2010, no. 3 (12), pp. 51–53.
2. Orlova, E.A. and Komarevtsev, V.N., Definition of DNA fragmentation in cells of renal tissue, Act. Probl. Obstet. Gynecol. Clin. Immunol. Med. Genet., 2001, no. 6, pp. 206–209.
3. Barycheva, L.Yu., Erdni-Goryaeva, N.E., and Golubeva, M.V., Expression of apoptosis markers in children with type 1 diabetes, Med. Bull. North Caucasus, 2013, vol. 8, no. 3, pp. 86–88.
4. Brownlee, M., The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 2005, vol. 54, no. 6, pp. 1615–1625.
5. Kannan, Y., Tokunaga, M., Moriyama, M., Kinoshita, H., and Nakamura, Y., Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin- induced diabetic mice, Clin. Exp. Immunol., 2004, vol. 137, no. 2, pp. 263–271.
6. Nabi, A.H., Islam, L.N., Rahman, M.M., and Biswas, K.B., Polymorphonuclear neutrophil dysfunctions streptozotocin-induced type 1 diabetic rats, J. Biochem. Mol. Biol., 2005, vol. 38, no. 6, pp. 661–667.
7. Elmore, S., Apoptosis: a review of programmed cell death, Toxicol. Pathol., 2007, vol. 35, no. 4, pp. 495–516.
8. Ryazanceva, N.V., Novickiy, V.V., Chasovskih, N.Yu., Kaigorodova, E.V., Starikova, E.G., Starikov, U.V., Radzivil, T.T., and Krat, I.V., The role of redox-dependent signal systems in the regulation of apoptosis under oxidative stress condition, Tsitologiya, 2009, vol. 51, no. 4, pp. 329–333.
9. Chasovskikh, N.Yu., Role of protein kinases JNK and p38 in regulation of mononuclear leucocytes apoptosis in oxidative stress, Bull. Sib. Med., 2008, no. 3, pp. 38–43.
10. Chumakov, P.M., Tumor protein p53 and its universal function in a multicellular organism, Adv. Biol. Chem., 2007, vol. 47, pp. 3–52.
11. Chumakov, P.M., The function of the gene p53: the choice between life and death, Biochemistry, 2000, vol. 65, no. 1, pp. 34–47.
12. Fink, S.L. and Cookson, B.T., Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells, Infect. Immun., 2005, vol. 73, no. 4, pp. 1907–1916.
13. Liu, B., Chen, Y., and Clair, D.K.St., ROS and p53: versatile partnership, Free Radic. Biol. Med., 2008, vol. 44, no. 8, pp. 1529–1535.
14. Sinha K., Das, J., Pal, P.B., and Sil, P.C., Oxidative stress: the mitochondria-dependent and mitochondriaindependent pathways of apoptosis, Arch. Toxicol., 2013, vol. 87, no. 7, pp. 1157–1180.
15. Bra, M., Kwinana, B., and Suzin, S.A., The mitochondria in programmed cell death: the death of the various mechanisms, Biochemistry, 2005, vol. 70, no. 2, pp. 284–293.
16. Akl, H., Vervloessem, T., Kiviluoto, S., Bittremieux, M., Parys, J.B., de Smedt, H., and Bultynck, G., A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum, Biochim. Biophys. Acta, 2014, vol. 1843, no. 10, pp. 2240–2252.
17. Greenberg, E.F., Lavik, A.R., and Distelhorst, C.W., Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment, Biochim. Biophys. Acta, 2014, vol. 1843, no. 10, pp. 2205–2210.
18. Sudakov, N.P., Nikiforov, S.B., Konstantinov, Y., and Lepehova, S.A., The role of mitochondria in the implementation of the mechanisms of programmed cell death, Bull. East Sib. Sci. Center Acad. Med. Sci., 2007, no. 1 (53), pp. 103–107.
19. Fruehauf, J.P. and Meyskens, F.L., Reactive oxygen species: a breath of life or death?, Clin. Cancer Res., 2007, vol. 13, no. 3, pp. 789–794.
20. Siles, E., Martinez-Lara, E., Núñez, M.I., Mucoz-Gámez, J.A., Martín-Oliva, D., Valenzuela, M.T., Peinado, M.A., Ruiz de Almodóvar, J.M., and Javier Oliver, F., PARP-1-dependent 3-nitrotyrosine protein modification after DNA damage, J. Cell Biochem., 2005, vol. 96, no. 4, pp. 709–715.
21. Grinevich, I. and Kamyshny, A., Influence of the effect of experimental diabetes mellitus on the protein expression of apoptotic regulators Bcl-2 and p53 in the lymphoid follicles of the spleen, Morphology, 2010, vol. 4, no. 4, pp. 19–23.
22. Arndt, M.A., Battaglia, V., Parisi, E., Lortie, M.J., Isome, M., Baskerville, Ch., Pizzo, D.P., Ientile, R., Colombatto, S., Toninello, A., and Satriano, J., The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis, Am. J. Physiol. Cell Physiol., 2009, vol. 296, no. 6, pp. C1411–C1419.
23. Haenisch, B., von Kügelgen, I., Bonisch, H., Göthert, M., Sauerbruch, T., Schepke, M., Marklein, G., Höfling, K., Schröder, D., and Molderings, G.J., Regulatory mechanisms underlying agmatine homeostasis in humans, Am. J. Physiol. Gastrointest. Liver Physiol., 2008, vol. 295, no. 5, pp. G1104–G1110.
24. Ferents, I.V., Lyuta, M.Ya., Brodyak, I.V., Burda, V.A., Fedorovych, A.M., and Sybirna, N.O., Effect of agmatine on the system of l-arginine/no in peripheral blood leukocytes under the condition of experimental diabetes mellitus, Med. Chem., 2011, vol. 13, no. 4, pp. 26–28.
25. Ferents, I.V., Brodyak, I.V., Lyuta, M.Ya., Burda, V.A., Gavrylyshyn, G.S., and Sybirna, N.O., Effect of agmatine on the blood system parameters of rats under the condition of experimental diabetes mellitus, Studia Biol., 2012, vol. 6, no. 3, pp. 65–72.
26. Lapovets, L.E. and Lutsyk, B.D., Handbook of Laboratory Immunology, Lviv, 2002.
27. Laemmly, U., Beguin, F., and Gujer-Kellenberg, G., A factor preventing the major head protein of bacteriophage T4 from random aggregation, J. Mol. Biol., 1970, vol. 47, no. 1, pp. 69–85.
28. Berkalo, L.V., Bobovych, O.V., and Bobrova, N.A., Methods of Clinical and Experimental Research in Medicine, Poltava: Polimet, 2003.
29. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C., A novel assay for apoptosis. flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V, J.Immunol. Methods, 1995, vol. 184, no. 1, pp. 39–51.
30. Gow, A.J., Farkouh, C.R., Munson, D.A., Posencheg, M.A., and Ischiropoulos, H., Biological significance of nitric oxide-mediated protein modifications, Am. J. Physiol. Lung Cell Mol. Physiol., 2004, vol. 287, no. 2, pp. L262–L268.
31. Souza, J.M., Peluffo, G., and Radi, R., Protein tyrosine nitration—functional alteration or just a biomarker?, Free Radic. Biol. Med., 2008, vol. 45, no. 4, pp. 357–366.
32. Meretskyy, V.M. and Korda, M.M., Relationship between oxidative stress and neutrophil apoptosis intensity in traumatic cranial injury associated with diabetes, World Med. Biol., 2013, no. 4, pp. 75–79.
33. Szabo, C., Ischiropoulos, H., and Radi, R., Peroxynitrite: biochemistry, pathophysiology and development of therapeutics, Nat. Rev. Drug. Discov., 2007, vol. 6, no. 8, pp. 662–680.
34. Arya, A.K., Pokharia, D., Mishra, M., Kumar, H., and Tripathi, K., Impact of lymphocyte apoptosis in diabetes mellitus, Asian J. Med. Sci., 2011, no. 2, pp. 1–6.
35. Salvemini, D., Doyle, T.M., and Cuzzocrea, S., Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation, Biochem. Soc. Trans., 2006, vol. 34.
36. Hong, S., Kim, C.Y., Lee, J.E., and Seong, G.J., Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis, Life Sci., 2009, vol. 84, nos. 1–2, pp. 28–32.
37. Hong, S., Lee, J.E., Kim, C.Y., and Seong, G.J., Agmatine protects retinal ganglion cells from hypoxiainduced apoptosis in transformed rat retinal ganglion cell line, BMC Neurosci., 2007, vol. 8, p. 81.
38. Hong, S., Park, K., Kim, C.Y., and Seong, G.J., Agmatine inhibits hypoxia-induced TNF-alpha release from cultured retinal ganglion cells, Biocell, 2008, vol. 32, no. 2, pp. 201–205.
39. Condello, S., Curro, M., Ferlazzo, N., Caccamo, D., Satriano, J., and Ientile, R., Agmatine effects on mitochondrial membrane potential and NF-?B activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells, J. Neurochem., 2011, vol. 116, no. 1, pp. 67–75.
40. Pegg, A.E., Mammalian polyamine metabolism and function, IUBMB Life, 2009, vol. 61, no. 9, pp. 880–894.
41. Battaglia, V., Grancara, S., Satriano, J., Saccoccio, S., Agostinelli, E., and Toninello, A., Agmatine prevents the Ca2+-dependent induction of permeability transition in rat brain mitochondria, Amino Acids, 2010, vol. 38, no. 2, pp. 431–437.
42. Battaglia, V., Rossi, C.A., Colombatto, S., Grillo, M.A., and Toninello, A., Different behavior of agmatine in liver mitochondria: inducer of oxidative stress or scavenger of reactive oxygen species?, Biochim. Biophys. Acta, 2007, vol. 1768, no. 5, pp. 1147–1153.
43. Gardini, G., Cabella, C., Cravanzola, C., Vargiu, C., Belliardo, S., Testore, G., Solinas, S.P., Toninello, A., Grillo, M.A., and Colombatto, S., Agmatine induces apoptosis in rat hepatocyte cultures, J. Hepatol., 2001, vol. 35, no. 4, pp. 482–489.
44. 2+ and monoamines: different behaviour of liver and brain mitochondria in undergoing permeability transition, Amino Acids, 2012, vol. 42, nos. 2–3, pp. 751–759.